Gastric and small bowel ileus after severe burn in rats: the effect of cyclooxygenase-2 inhibitors

Burns. 2009 Dec;35(8):1180-4. doi: 10.1016/j.burns.2009.02.022. Epub 2009 May 22.

Abstract

Gastrointestinal (GI) ileus is a common complication after severe burns. Selective cyclooxygenase-2 inhibitors (COX-2i) improved post-operative ileus, but its effect on burn-induced GI dysmotility is unknown. Our aim was to test whether a COX-2i improves gastric emptying (GE) and small bowel transit (SBT) after burn. Experiment on GE: rats were anesthetized and randomized into sham/scald burn, treated/untreated with COX-2i. Six hours after burn, rats received a phenol red meal and were sacrificed 30 min later. Gastric emptying was determined based on the percentage of phenol red recovered in harvested stomachs. Experiment on SBT: rats received a duodenostomy and were scald/sham burned 5 days later. Six hours after burn, rats received a phenol red meal through the duodenostomy catheter and were sacrificed 100 min later. Geometric center (GC) was calculated for SBT. GE was decreased significantly in burned vs. sham animals (p<0.001). SBT was significantly impaired in burned vs. sham animals (p<0.001). The COX-2i improved GE in the burn rats but not GE in the control rats or SBT in the burn rats. COX-2i improves burn-induced delayed GE, suggesting the mediation of the latter via the prostaglandin pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Burns / complications*
  • Burns / physiopathology
  • Cyclooxygenase 2 Inhibitors / pharmacology
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Disease Models, Animal
  • Drug Evaluation, Preclinical / methods
  • Gastric Emptying / drug effects
  • Gastrointestinal Transit / drug effects
  • Ileus / drug therapy*
  • Ileus / etiology*
  • Ileus / physiopathology
  • Intestine, Small / physiopathology*
  • Male
  • Phenolsulfonphthalein
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Cyclooxygenase 2 Inhibitors
  • Pyrazoles
  • 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole
  • Phenolsulfonphthalein